CA2444814C - Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures - Google Patents

Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures Download PDF

Info

Publication number
CA2444814C
CA2444814C CA002444814A CA2444814A CA2444814C CA 2444814 C CA2444814 C CA 2444814C CA 002444814 A CA002444814 A CA 002444814A CA 2444814 A CA2444814 A CA 2444814A CA 2444814 C CA2444814 C CA 2444814C
Authority
CA
Canada
Prior art keywords
coating layer
composition
cellulose
poly
methacrylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002444814A
Other languages
English (en)
Other versions
CA2444814A1 (fr
Inventor
Gregory Paul Dittmar
Joseph Michael Amante
Tony Ryan Cronk
Daniel Gary Newby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Pharmaceuticals International Ltd
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29783760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2444814(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority claimed from CA002359812A external-priority patent/CA2359812C/fr
Publication of CA2444814A1 publication Critical patent/CA2444814A1/fr
Application granted granted Critical
Publication of CA2444814C publication Critical patent/CA2444814C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
CA002444814A 2001-10-24 2001-10-24 Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures Expired - Lifetime CA2444814C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002359812A CA2359812C (fr) 2000-11-20 2001-10-24 Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002359812A Division CA2359812C (fr) 2000-11-20 2001-10-24 Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures

Publications (2)

Publication Number Publication Date
CA2444814A1 CA2444814A1 (fr) 2002-05-20
CA2444814C true CA2444814C (fr) 2009-06-09

Family

ID=29783760

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002444814A Expired - Lifetime CA2444814C (fr) 2001-10-24 2001-10-24 Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures

Country Status (1)

Country Link
CA (1) CA2444814C (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2687130C (fr) * 2007-05-07 2017-10-03 Evonik Roehm Gmbh Formes posologiques solides comprenant un revetement gastroresistant et presentant une liberation acceleree du medicament
EP3162362A1 (fr) 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Comprimé optimisé a une haute dose contenant de la mesalazine

Also Published As

Publication number Publication date
CA2444814A1 (fr) 2002-05-20

Similar Documents

Publication Publication Date Title
CA2359812C (fr) Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures
AU2002226955B2 (en) Pharmaceutical dosage form with multiple coatings
US5686105A (en) Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5814336A (en) Pharmaceutical dosage form for colonic delivery
EP0932396B1 (fr) Forme posologique pharmaceutique comportant plusieurs enrobages polymeres enteriques, destinee a agir dans le colon
US5843479A (en) Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US6270798B2 (en) Lozenge for the modified releasing of active substances in the gastrointestinal tract
WO1996036338A1 (fr) Forme galenique de bisacodyle destinee a etre liberee dans le colon
CA2271569C (fr) Forme galenique pharmaceutique comportant des revetements enteriques polymeres multiples pour administration dans le colon
CA2444814C (fr) Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures
CA2271560C (fr) Forme galenique pharmaceutique concue pour etre administree dans le colon
JP2012107058A (ja) 複数のコーティングを有する医薬剤形

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20211025